{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:07:50Z","timestamp":1746850070218,"version":"3.40.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,9]]},"DOI":"10.7759\/cureus.83781","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:45:03Z","timestamp":1746791103000},"source":"Crossref","is-referenced-by-count":0,"title":["Catastrophic Antiphospholipid Syndrome Following Treated Antineutrophilic Cytoplasmic Antibody (ANCA) Vasculitis: Unusual Case Presentation"],"prefix":"10.7759","author":[{"given":"Ahmad","family":"Makeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourah A","family":"Alorainan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar  A","family":"Baloush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghdah","family":"Khadwardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Awais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-1-60","article-title":"ANCA-associated vasculitis","volume":"17","author":"Yates M","year":"2017","unstructured":"Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Lond). 2017, 17:60-4. 10.7861\/clinmedicine.17-1-60","journal-title":"Clin Med (Lond)"},{"key":"ref2","article-title":"Granulomatosis With Polyangiitis","author":"Rout P","year":"2025","unstructured":"Rout P, Garlapati P, Qurie A. Granulomatosis With Polyangiitis. StatPearls [Internet], Treasure Island (FL); 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12860\/jnp.2014.03","article-title":"Catastrophic antiphospholipid syndrome: a clinical review","volume":"3","author":"Nayer A","year":"2014","unstructured":"Nayer A, Ortega LM. Catastrophic antiphospholipid syndrome: a clinical review. J Nephropathol. 2014, 3:9-17. 10.12860\/jnp.2014.03","journal-title":"J Nephropathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.09.009","article-title":"Vasculitis in antiphospholipid syndrome","volume":"41","author":"Lally L","year":"2015","unstructured":"Lally L, Sammaritano LR. Vasculitis in antiphospholipid syndrome. Rheum Dis Clin North Am. 2015, 41:109-23, ix. 10.1016\/j.rdc.2014.09.009","journal-title":"Rheum Dis Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010668","article-title":"Catastrophic antiphospholipid syndrome","volume":"25","author":"Bitsadze V","year":"2024","unstructured":"Bitsadze V, Yakubova F, Khizroeva J, et al.. Catastrophic antiphospholipid syndrome. Int J Mol Sci. 2024, 25:10.3390\/ijms25010668","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson RA","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, et al.. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003, 12:530-4. 10.1191\/0961203303lu394oa","journal-title":"Lupus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodr\u00edguez-Pint\u00f3 I","year":"2016","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Moitinho M, Santacreu I, et al.. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016, 15:1120-4. 10.1016\/j.autrev.2016.09.010","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312436866","article-title":"CAPS registry","volume":"21","author":"Cervera R","year":"2012","unstructured":"Cervera R. CAPS registry. Lupus. 2012, 21:755-7. 10.1177\/0961203312436866","journal-title":"Lupus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320951260","article-title":"16th International Congress on Antiphospholipid Antibodies Task Force report on catastrophic antiphospholipid syndrome","volume":"29","author":"Cervera R","year":"2020","unstructured":"Cervera R, Rodr\u00edguez-Pint\u00f3 I, Legault K, Erkan D. 16th International Congress on Antiphospholipid Antibodies Task Force report on catastrophic antiphospholipid syndrome. Lupus. 2020, 29:1594-600. 10.1177\/0961203320951260","journal-title":"Lupus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2019.1095","article-title":"Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis","volume":"71","author":"Manzella DJ","year":"2019","unstructured":"Manzella DJ, Vicente L, P\u00e9rez de la Hoz AA, et al.. Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis. Reumatismo. 2019, 71:92-8. 10.4081\/reumatismo.2019.1095","journal-title":"Reumatismo"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreue.2018.08.004","article-title":"Microscopic polyangiitis and antiphospholipid syndrome. An uncommon association","volume":"26","author":"L\u00f3pez-Villegas VJ","year":"2019","unstructured":"L\u00f3pez-Villegas VJ, Medina-Morales DA, Saldarriaga-Rivera LM. Microscopic polyangiitis and antiphospholipid syndrome. An uncommon association. Revista Colombiana de Reumatolog\u00eda (English Edition. 2019, 26:285-9. 10.1016\/j.rcreue.2018.08.004","journal-title":"Revista Colombiana de Reumatolog\u00eda (English Edition"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(95)80037-9","article-title":"Vasculitis associated with antiphospholipid syndrome","volume":"24","author":"Norden DK","year":"1995","unstructured":"Norden DK, Ostrov BE, Shafritz AB, Von Feldt JM. Vasculitis associated with antiphospholipid syndrome. Semin Arthritis Rheum. 1995, 24:273-81. 10.1016\/s0049-0172(95)80037-9","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2018.10.014","article-title":"Persistent antiphospholipid antibodies are associated with thrombotic events in ANCA-associated vasculitis: A retrospective monocentric study","volume":"39","author":"Yoo J","year":"2019","unstructured":"Yoo J, Ahn SS, Jung SM, et al.. Persistent antiphospholipid antibodies are associated with thrombotic events in ANCA-associated vasculitis: A retrospective monocentric study. Nefrologia (Engl Ed). 2019, 39:395-401. 10.1016\/j.nefro.2018.10.014","journal-title":"Nefrologia (Engl Ed)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac031","article-title":"Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"33","author":"Suzuki J","year":"2023","unstructured":"Suzuki J, Furuta S, Sugiyama T, et al.. Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Mod Rheumatol. 2023, 33:346-51. 10.1093\/mr\/roac031","journal-title":"Mod Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366693-catastrophic-antiphospholipid-syndrome-following-treated-antineutrophilic-cytoplasmic-antibody-anca-vasculitis-unusual-case-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:45:04Z","timestamp":1746791104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366693-catastrophic-antiphospholipid-syndrome-following-treated-antineutrophilic-cytoplasmic-antibody-anca-vasculitis-unusual-case-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.83781","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}